I wonder if it comes down to the tox study... a scientist might be a bit embarrassed to name drop ANP to then follow up with.. but they are still in a toxicology study for US approval. (true to your point those guys didn't know much) But Pat knows about us, she handballed it on, when she should have talked into our results a little on our behalf.
I've done a bit of research lately on these other drugs that may get approval later this year and the more I research the more confident I am; the competition still declines, and ours doesn't, that's key.
Other indications, page-21
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.8¢ | $58.09K | 574.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38503 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 194063 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |